NVST — Envista Holdings Corp

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1757073 ·
Last close
$22.72
Market Cap
$3.65B
52W High
$30.42
52W Low
$18.77
ADV30
2,685,378
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 730,500,000 407,000,000 80,300,000 53,700,000 5,597,100,000 1,125,600,000 2,520,800,000
Mar 2026 705,500,000 390,100,000 66,200,000 38,700,000 5,578,000,000 1,082,800,000 2,498,500,000
Dec 2025 750,600,000 410,600,000 93,000,000 32,900,000 5,679,000,000 1,211,700,000 2,572,700,000
Sep 2025 669,900,000 370,200,000 57,500,000 -30,300,000 5,642,500,000 1,133,900,000 2,554,300,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$302,600,000
Investing CF
$-108,400,000
Financing CF
$-173,200,000
CapEx
$-54,500,000
Dividends Paid
—
Buybacks
$-169,300,000
EPS Diluted TTM
$0.58
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-348,000,000
Inventory
$290,900,000
Receivables
$436,900,000
ST Investments
—
EBIT TTM
$269,500,000
Pretax Income TTM
$234,100,000
Interest Exp TTM
$35,400,000
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,856,499,968
EBITDA
$406,200,000
Free Cash Flow
$267,887,504
Enterprise Value
$4,566,182,400
Total Cash
$1,125,600,000
Total Debt
$1,588,000,000
Shares Out
160,617,709
Trailing EPS
$0.58
Book Value
$19.16
ROE
3.1%
ROA
3.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,719,500,000 235,800,000 47,000,000 5,679,000,000 2,572,700,000 3,106,300,000 275,700,000
Dec 2024 2,510,600,000 137,200,000 -1,118,600,000 5,350,500,000 2,415,700,000 2,934,800,000 336,500,000
Dec 2023 2,566,500,000 314,900,000 -100,200,000 6,605,100,000 2,431,200,000 4,173,900,000 275,700,000
Dec 2022 2,569,100,000 343,200,000 243,100,000 6,587,000,000 2,380,100,000 4,206,900,000 182,700,000

TTM Snapshot

Revenues TTM
$2,808,100,000
NetIncome TTM
$67,700,000
OpCashFlow TTM
—
Assets (Latest)
$5,578,000,000
Forward EPS
$1.67

Max Pain — expiry 2026-12-18

max pain strike: $25.00 · spot: $22.72 · call oi: 6,648 · put oi: 6,527

Peers — same industry

TickerNameMarket CapLastDaily %
PLSE PULSE BIOSCIENCES, INC. $3.56B $49.98 —
ICUI ICU MEDICAL INC/DE $3.93B $157.18 —
IRTC iRhythm Holdings, Inc. $3.38B $102.60 —
HTFL Heartflow, Inc. $4.14B $47.63 —
LIVN LivaNova PLC $4.17B $75.91 —

News headlines (Yahoo Finance, 1h cache)

Envista Schedules Third Quarter 2026 Earnings Call
2026-10-06 20:15 · Yahoo
1 of Wall Street’s Favorite Stocks to Keep an Eye On and 2 We Ignore
2026-10-02 11:42 · Yahoo
NVST vs. ABT: Which Stock Is the Better Value Option?
2026-09-25 14:40 · Yahoo
Envista Holdings (NVST), Why Is Investor Attention Building Now?
2026-09-21 23:16 · Yahoo
Should Value Investors Buy Envista (NVST) Stock?
2026-09-18 13:40 · Yahoo
NVST or ABT: Which Is the Better Value Stock Right Now?
2026-09-09 15:40 · Yahoo
Envista Announces Participation in Baird 2026 Global Healthcare Conference
2026-09-08 20:10 · Yahoo
Envista Holdings Shares Rise After JPMorgan Upgrade
2026-09-03 13:45 · Yahoo
Leaner Operations and Improving Dental Demand Position Envista Holdings Corp. (NVST) for Multi-Year Growth
2026-10-01 13:43 · Yahoo
Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls
2026-09-03 13:31 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.